Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 2 Interventional Results available

A Dose-ranging Study of the Efficacy of ESN364 in Postmenopausal Women Suffering Vasomotor Symptoms (Hot Flashes)

ClinicalTrials.gov ID: NCT03192176

Public ClinicalTrials.gov record NCT03192176. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Oct 18, 2026, 5:34 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Randomized, Placebo-Controlled, Double-Blind, Dose-Ranging, Phase 2b Study to Investigate the Efficacy of ESN364 in Postmenopausal Women Suffering From Vasomotor Symptoms (Hot Flashes)

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

This study determined the effects of different doses and dosing regimens of ESN364 on the frequency and severity of hot flashes. The treatment was administered for 12 weeks to postmenopausal women, aged 40 to 65, suffering at least 50 moderate to severe hot flashes per week.

Study identification

NCT ID
NCT03192176
Recruitment status
Completed
Study type
Interventional
Phase
Phase 2
Enrollment
356 participants

Conditions and interventions

Interventions

Drug

Eligibility (public fields only)

Age range
40 Years to 65 Years
Sex
Female
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Jul 19, 2017 (Actual)
Primary completion
Sep 19, 2018 (Actual)
Completion
Sep 19, 2018 (Actual)
Last update posted
Nov 26, 2024

2017 – 2018

United States locations

U.S. sites
51
U.S. states
24
U.S. cities
49
Facility City State ZIP Site status
Research Site Anniston Alabama 36207 —
Research Site Birmingham Alabama 35205 —
Research Site Phoenix Arizona 85023 —
Research Site Los Angeles California 90057 —
Research Site Oceanside California 92056 —
Research Site Panorama City California 91402 —
Research Site 052 Sacramento California 95821 —
Research Site 058 Sacramento California 95821 —
Research Site San Diego California 92114 —
Research Site Thousand Oaks California 91360 —
Research Site Valley Village California 91607 —
Research Site Denver Colorado 80209 —
Research Site Milford Connecticut 06460 —
Research Site Crystal River Florida 34429 —
Research Site DeLand Florida 32720 —
Research Site Jupiter Florida 33458 —
Research Site Lake Worth Florida 33461 —
Research Site Miami Florida 33144 —
Research Site Ormond Beach Florida 32174 —
Research Site Port Saint Lucie Florida 34952 —
Research Site Atlanta Georgia 30312 —
Research Site Norcross Georgia 30092 —
Research Site Meridian Idaho 83642 —
Research Site Champaign Illinois 61820 —
Research Site Marrero Louisiana 70072 —
Research Site Elkridge Maryland 21075 —
Research Site Watertown Massachusetts 02472 —
Research Site Lincoln Nebraska 68510 —
Research Site Norfolk Nebraska 68701 —
Research Site Las Vegas Nevada 89123 —
Research Site New York New York 10032 —
Research Site Williamsville New York 14221 —
Research Site Cincinnati Ohio 45267 —
Research Site Cleveland Ohio 44122 —
Research Site Columbus Ohio 43210 —
Research Site Columbus Ohio 43213 —
Research Site Oklahoma City Oklahoma 73112 —
Research Site Philadelphia Pennsylvania 19140 —
Research Site Mt. Pleasant South Carolina 29464 —
Research Site Clarksville Tennessee 37040 —
Research Site Kingsport Tennessee 37660 —
Research Site Houston Texas 77058 —
Research Site Hurst Texas 76054 —
Research Site Lampasas Texas 76550 —
Research Site Plano Texas 75093 —
Research Site San Antonio Texas 78229 —
Research Site Riverton Utah 84065 —
Research Site Charlottesville Virginia 22911 —
Research Site Vienna Virginia 22182 —
Research Site Seattle Washington 98105 —
Research Site Spokane Washington 99207 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT03192176, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Nov 26, 2024 · Synced Oct 18, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT03192176 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →